Results

Total Results: 1,540 records

Showing results for "month".

141. Autism Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_surveillance.pdf
     October 01, 2012 - evidence for parent training is possibly out of date due to two new high quality RCTs, one with six month … “More than Words,” language program reported there were no main effects of the intervention at 9 month … At 12 month f/u gains were either maintained or improved. … Both groups got 10 hrs per week in classrorom, 1.5 hrs parent training per month, and 38 total hours … Subjects identification of non- verbal social cues significantly improved and was maintained at 3 month

142. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
     January 01, 2012 - The cost was reported to be about $1,000 per injection (per month) when first approved for opioid addiction … reports of slow adoption for this indication have purportedly increased the cost to about $1,300 per month … It is removed at the end of the 6- month period. 15,18 A phase III trial of the implant was recently … for this indication is intended to be dosed at 380 mg intramuscularly every 4 weeks, or once per month … Titan Pharmaceuticals announces positive results of six-month open-label safety retreatment study of

143. Heart-Failure-Transition-Care Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_clinician.pdf
     October 01, 2015 - Transitional Care Interventions To Prevent Readmissions for People With Heart Failure Focus of This Summary This is a summary of a systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and harms of transitional care interventions (defined in Table 1) that aim to reduce readmiss…

144. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - (MODERATE) A new 6 month RCT of MTX versus placebo found no significant effect on: PsARC, ACR20, … or infliximab), MTX plus anti-TNF produced similar disease One new non-randomized, non- blinded 6 month … (INSUFFICIENT) A new 6 month RCT of MTX vs placebo reported no significant effect on tender or swollen … cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month … Abatacept in the treatment of patients with psoriatic arthritis: results of a six- month, multicenter

145. Diagnosis and Management of Febrile Infants (0–3 Months) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/febrile-infants-diagnosis-management/research

146. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … group than the 3- month group (4.5 percent vs. 2.9 percent) and higher incidence of hot flashes ( … Six-month concomitant and adjuvant hormonal treatment with external beam irradiation is inferior to … The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … group than the 3- month group (4.5 percent vs. 2.9 percent) and higher incidence of hot flashes (87

147. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … group than the 3- month group (4.5 percent vs. 2.9 percent) and higher incidence of hot flashes ( … Six-month concomitant and adjuvant hormonal treatment with external beam irradiation is inferior to … The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … group than the 3- month group (4.5 percent vs. 2.9 percent) and higher incidence of hot flashes (87

148. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - 200 mg or 400 mg, and 54% and 59%, respectively, achieved the sUA target of less than 6.0 mg/dL by month … treated with lesinurad 200 mg or 400 mg, and 55% and 67%, respectively, achieved the sUA target by month … treated with lesinurad and febuxostat achieved the target sUA-level goal of less than 5.0 mg/dL at month … Patients treated with lesinurad 200 mg and febuxostat did not achieve a statistical improvement at month

149. Appendix-Table-B-1-Observational-Studies (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
     March 20, 2021 - Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month … CLIA Abbott SARS-CoV-2 IgG NR explicitly, but authors began recording new infections approximately 1 month

150. Attention Deficit Hyperactivity Disorder: Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
     October 01, 2011 - Attention Deficit Hyperactivity Disorder: Executive Summary                                                                                                                                                                                                                                                       …

151. Management of Uterine Fibroids - Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
     December 01, 2017 - magnitude of fibroid volume reduction was greater at 12 months after ultrasound destruction than at 1 month … Two additional studies reported no recurrences at 6 month followup. … Moderate Improvements in arms reporting these outcomes, with reductions generally maintained over 6 month

152. Methods Research Report: Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of Chronic Pain Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
     November 01, 2020 - testing was that the chronic pain report restricted inclusion to studies with followup of at least 1 month … small number of studies included in each monthly update search, we tested the update searches in two month … ranged from small to moderate, totaling 2.0 to 13.2 hours when update searches were combined in two month … blocks (1.0 to 6.1 hours per month). … Vagal modulation and symptomatology following a 6- month aerobic exercise program for women with fibromyalgia

153. Systematic Review Update: Noninvasive Nonpharmacologic Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
     December 11, 2018 - least 1 year); we will focus on longer-term (>1 year) effects where possible o Studies with <1 month … o Chronic headache is defined as 15 or more days each month for at least 12 weeks or history of headache … months), intermediate term (≥6 to <12 months) and long term (≥12 months); focus on longer term (≥12 month … • Studies with <1 month followup after treatment CBD = cannabidiol; FDA = Food and Drug Administration … this review is on randomized controlled trials (RCTs) reporting on longer-term outcomes (at least one month

154. Bar-Cohen II_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/bar-cohen-ii_eccs2012.pdf
     January 01, 2012 - Cancer  Coalition  included   an analysis of media coverage of during Breast Cancer Awareness Month

155. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
     January 01, 2007 - Layout 1 This report is an update to a Comparative Effectiveness Review on management strategies for renal artery stenosis (RAS) from October 2006. The systematic review included all studies of patients with atherosclerotic RAS (ARAS) that compared two or more interventions. It also reviewed recent prospective cohort…

156. S9 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s9.pdf
     October 01, 2007 - Medicare Part D defined the standard prescription drug benefit, with an average premium of about $32 per month … Government payments to Part D plans are based on risk-adjusted per member per month capitated amounts

157. FRN 35 - Preventive Pharmacological Treatments for Migraine in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
     April 01, 2013 - and chronic indicating 15 or more headache days per month). … Some individuals may suffer from an average of five headaches per month and others 15. … ) and chronic (15 or more headache days per month). … Some individuals may suffer from an average of five headaches per month and others 15. … MONTH 2013 2. Headache Classification Subcommittee of the International Headache Society.

158. QR Medica Web Site (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-1stplace-qrmedica.pdf
     January 01, 2013 - QR Medica Web Site QR Medica Home For Clinicians For Patients and Guardians About This Project References This resource is meant to be used by nurse practitioners, physician assistants and patients alike. For the providers, the resource contains evidence based care recommendations and clinical tools. Patients …

159. Politi (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
     May 29, 2025 - MD: (discusses side effects)…but  you can try it, and we can meet  again in 1 month

160. Glaucoma-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
     January 01, 2013 - Every month since the CER’s original release, we received any FDA updates on the included treatments … Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized … tx (prostaglandin+ß blockerbrimonidinedorzolamide, brinzolamide, or FC dorzolamide-timolol 12 month … patients (67 completed) age not specified Transition from Latanoprost to BAK-free travoprost 12 month … brimonidine/timolol FC 2-month timolol run in 3 months tx w/ each therapy No SAEs were reported